Key result
In CAD patients under 60 years old, overall mortality did not differ between CABG and PCI, though both revascularization strategies had lower mortality than medical therapy.
Why the study?
The study was conducted to estimate death probabilities after CABG, PCI, and medical therapy in patients under 60 years old.
Does revascularization (CABG or PCI) reduce mortality compared to medical therapy in CAD patients under 60 years old?
Meta-Analysis (n=16,410)
Does revascularization (CABG or PCI) reduce mortality compared to medical therapy in CAD patients under 60 years old?
In CAD patients under 60 years old, overall mortality was 3.6% after CABG, 4.3% after PCI, and 9.7% after medical therapy over a mean follow-up of 3.7 years.
Answers are grounded in this paper and cite their sources.
Revascularization with CABG or PCI should be prioritized over medical therapy in CAD patients under 60; confirms mortality benefit of invasive strategies in younger adults.
To estimate death probabilities after coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) in patients under 60 years old. We conducted a search systematic on PubMed, Embase, Cochrane Library, and Web of Science up to January 2021. The study included three parts. In the probabilities part (A), Comprehensive Meta-Analysis, and in the comparison parts (B and C), Review Manager was used in conducting meta-analyses. Nine studies consisting of 16,410 people with a mean age of 51.2 ± 6 years were included in the meta-analysis. Over a mean follow-up of 3.7 ± 2 years, overall mortality after CABG, PCI and MT was 3.6% (95% CI 0.021-0.061), 4.3% (95% CI 0.023-0.080) and 9.7% (95% CI 0.036-0.235), respectively. The length of follow-up periods was almost the same and did not differ much (p = 0.19). In Part B (without adjustment of baseline characteristics), 495 (4.0%) of 12,198 patients assigned to CABG died compared with 748 (4.5%) of 16,458 patients assigned to PCI (risk ratio [RR]: 0.77, 95% CI 0.50-1.20; p = 0.25). Seventy-four (3.5%) of 2120 patients assigned to CABG and 68 (4.2%) of 1621 patients assigned to PCI died compared with 103 (9.5%) of 1093 patients assigned to MT in equal follow-up periods (CABG-MT: RR 0.34; 95% CI 0.23-0.51; p < 0.002) (PCI-MT: RR 0.40; 95% CI 0.30-0.53; p = 0.02). In Part C, overall mortality after PCI in PACD patients with STEMI was higher in elderly versus young (RR 2.64; 95% CI 2.11-3.30) and is lower in men versus women (RR 0.61; 95% CI 0.44-0.83). Mortality probabilities obtained are one of the most important factors of effectiveness in the economic evaluation studies; these rates can be used to determine the cost-effectiveness of procedures in CAD patients aged < 60 years.
No takes yet. Share an insight, caveat, or question.
Afrouzi et al. (2021) conducted a meta-analysis in Coronary artery disease (CAD) (n=16,410). Coronary artery bypass graft (CABG) vs. Percutaneous coronary intervention (PCI) was evaluated on Overall mortality (RR 0.77, 95% CI 0.50-1.20, p=0.25). In CAD patients under 60 years old, overall mortality did not differ between CABG and PCI, though both revascularization strategies had lower mortality than medical therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: